American drugmaker Pfizer and German pharmaceutical firm BioNTech will request Brazil's emergency use authorization for a COVID-19 vaccine the two firms are jointly developing, Edson Moreira, the coordinator of the trials in the South American country, said on Monday.

The University of Oxford says the late-stage trial of its COVID-19 vaccine in Brazil will continue following reports of a participant’s death, reports AP.